Endocrine Month in Review: October 2021

Editor's Note: Clicking in the center of a slide will redirect you to the article highlighted within that slide.

PreviousNext

Top Stories of October 2021:

1. ADA and EASD Publish Guidance on Diagnosis, Management of Type 1 Diabetes
   Published on September 30, the consensus report provides perspective on diagnosis and management of type 1 diabetes, including a diagnosis algorithm and insight on CGM specific to type 1 diabetes, which the writing group noted is lacking from previous guidance.
   
2. PTH Tablets Could Provide Oral Option for Osteoporosis Management
   A phase 2 trial presented at ASBMR provides insight into the effects of oral PTH tablets on bone health among postmenopausal women with osteoporosis.
   
3. Statin Initiation Could Contribute to Worsening Diabetes in Type 2 Diabetes
   Analysis of data from 83k matched pairs suggests statin initiation could increase a patient's odds of diabetes progression, including need for new glucose-lowering medications and new insulin use.
   
4. Around the Practice: Diabetes Management in 2021
   A panel of experts discuss the management of diabetes in 2021, with segments dedicated to using new technologies, management of cardiovascular comorbidities, and management of renal impairment.